Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tong-Xie-Yao-Fang Mechanism in IBS-D
NCT06737666Phase 1Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- May 2023
- Primary completion
- Oct 2025
- Modality
- HM (Herbal Medicine), TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 1, open-label trial of tongxieyaofang in Irritable bowel syndrome with diarrhea (IBS-D) (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: Fecal metagenomic detection of bacteria associated with Trp metabolism at 16 weeks, Serum detection by Elisa at 16 weeks and 3 more. Started May 2023; status: recruiting.
02
Drugs
tongxieyaofang
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT06737666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06737666.